🦊/Companies

Incanthera

Bradford, GB · 1 known investors

Find your way into Incanthera

Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.

Investors · 1

Companies House · registry record

View on Companies House ↗
Registered name
INCANTHERA PLC
Company number
11026926
Status
Active
Company type
Public limited company
Incorporated
23 Oct 2017
Registered office
C/O Gateley Legal, Ship Canal House, 98 King Street, Manchester, Greater Manchester, M2 4WU
Nature of business (SIC)
72190 — Other research and experimental development on natural sciences and engineering
Previous names
PROJECT BRADFORD PLC (20172020)
Accounts
last made up to 31 Mar 2025 · next due 30 Sept 2026
Confirmation statement
last made up to 22 Oct 2025 · next due 5 Nov 2026

Current officers · 6

  • Laura Jane Brogden director, appointed 13 Jul 2026
  • Werner Buerki director, appointed 13 Jul 2026
  • John Michael George Howes director, appointed 10 Jun 2024
  • Caroline Diana Murray director, appointed 23 Feb 2022
  • Stuart Kinnear Robertson director, appointed 3 Jun 2026
  • Simon Julian Ward director, appointed 23 Oct 2017

Source: Companies House public register · retrieved 6 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Incanthera do?
Incanthera develops and commercializes therapeutics derived from the Institute of Cancer Therapeutics in Bradford. The company operates a direct-to-consumer model with a global network of influencers and ambassadors, targeting multi-billion dollar markets outside the US.
Who are Incanthera's investors?
Incanthera's investors include IW Capital.
Where is Incanthera headquartered?
Incanthera is headquartered in Bradford, GB.